학술논문

Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.
Document Type
Article
Source
British Journal of Cancer. 10/14/2014, Vol. 111 Issue 8, p1605-1613. 9p. 7 Charts, 2 Graphs.
Subject
*COLON cancer
*ENDOSTATIN
*BLOOD serum analysis
*BIOMARKERS
*NEOVASCULARIZATION inhibitors
*DENDRITIC cells
*MAST cells
Language
ISSN
0007-0920
Abstract
Background:Endostatin, a fragment of collagen XVIII, is an endogenous angiogenesis inhibitor with anti-tumour functions. However, elevated circulating endostatin concentrations have been found in several human cancers including colorectal cancer (CRC).Methods:Serum endostatin levels were measured by enzyme-linked immunoassay from a series of 143 patients with CRC and from 84 controls, and correlated with detailed clinicopathological features of CRC, serum leukocyte differential count and C-reactive protein (CRP) levels.Results:Patients with CRC had higher serum endostatin levels than the controls (P=0.005), and high levels associated with age, tumour invasion through the muscularis propria and poor differentiation, but not with metastases. Endostatin levels showed a positive correlation with the markers of systemic inflammatory response and a negative correlation with the densities of tumour-infiltrating mast cells and dendritic cells. Collagen XVIII was expressed in tumour stroma most strikingly in blood vessels and capillaries, and in the muscle layer of the bowel wall.Conclusions:Elevated endostatin levels in CRC correlate with systemic inflammation and invasion through the muscularis propria. Increased endostatin level may be a result of invasion-related cleavage of collagen XVIII expressed in the bowel wall. The negative correlations between serum endostatin and intratumoural mast cells and immature dendritic cells may reflect angiogenesis inhibition by endostatin. [ABSTRACT FROM AUTHOR]